Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome
- 1 October 1994
- journal article
- clinical trial
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 72 (10) , 782-787
- https://doi.org/10.1007/bf00180547
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Phospholipase A2 — a mediator between proximal and distal effectors of inflammationImmunology Today, 1991
- Contribution of cortisol deficiency to septic shockThe Lancet, 1991
- Abrupt hemodynamic improvement in late septic shock with physiological doses of glucocorticoidsIntensive Care Medicine, 1991
- Modified photometric method for the determination of phospholipase A activitiesJournal of Molecular Medicine, 1989
- Differential regulation of lipopolysaccharide‐induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary‐adrenal axisEuropean Journal of Immunology, 1989
- Pathogenesis of hypotension in septic shockCritical Care Medicine, 1988
- Effect of High-Dose Glucocorticoid Therapy on Mortality in Patients with Clinical Signs of Systemic SepsisNew England Journal of Medicine, 1987
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 1987
- The Effects of High-Dose Corticosteroids in Patients with Septic ShockNew England Journal of Medicine, 1984
- ALDOSTERONE SECRETION IN STEROID-TREATED PATIENTS WITH ADRENAL SUPPRESSIONThe Lancet, 1971